RecruitingNCT04950218

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Sponsor

Herlev and Gentofte Hospital

Enrollment

1,000 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Summary

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.

Eligibility

Min Age: 18 Years

Inclusion Criteria1

Patients 18 years or older with a diagnosis of psoriasis will be invited to participate

Exclusion Criteria2

Patients not able to cooperate to the study
Patients unable understand and sign informed consent

Locations(1)

Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen

Hellerup, Copenhagne, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04950218

Related Trials

Mind Your Heart-II

NCT054311921 location

Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

NCT067824641 location

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288652 locations

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

NCT071917301 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370641 locations